Replies to post #17820 on DNAprint Genomics (DNAG)

[frogdreaming]

Cosmic,

I am afraid you have mischaracterized my response again. The truth is, I don't do 'belief' of any kind. Therefore to suggest that I 'believe' that DNAP is a pipedream, is incorrect.

Furthermore, while you have amassed an impressive list of 'possibilites' for drugs or classifiers that may or may not be in a DNAP pipeline. products that may or may not have any connection whatsoever to DNAP, based on a number of fairly tenuous connections and what can only be hopeful assumptions. What you may have failed to consider is that one of the basic attributes of a pipeline is that aside from it's ability to accept input at one end, eventually something has to come out the other. Otherwise it it is not a pipeline, but just a place where questionable concepts go to die.

For the sake of all of the loyal investors here, I hope that you are rewarded with at least a dribble of results from this 'pipeline' in the not too distant future. Some of those concepts have been reported to be imminent for a number of years now.

regards,
frog

[DRCAL]

DNAP is not a pipedream. The researchers there are for real. This doesn't mean that there won't be disappointments and failures.
Why don't investors check out the credentials of the research staff?
Unfortunately, intelligent investors who do extensive due diligence have to contend with the twin evils of naked short sellers and ignorant investors.